Medicinal product categorized by therapeutic role
|
Medicinal product acting as hemostatic (product)
Hemostatic agent
Haemostatic agent
Id
26370007
Status
Defined
Plays role
Hemostatic therapeutic role
|
Aminocaproic acid-containing product in oral dose form
1
Aminocaproic acid-containing product in parenteral dose form
1
Anti-inhibitor coagulant complex-containing product in parenteral dose form
1
Aprotinin-containing product in parenteral dose form
1
Carbazochrome-containing product in oral dose form
1
Carbazochrome-containing product in parenteral dose form
1
Coagulation factor IX-containing product in parenteral dose form
1
Coagulation factor VIIa-containing product in parenteral dose form
1
Coagulation factor VIII-containing product in parenteral dose form
3
Coagulation factor Xa-containing product in parenteral dose form
1
Coagulation factor XI-containing product in parenteral dose form
1
Coagulation factor XIII-containing product in parenteral dose form
1
Desmopressin-containing product in nasal dose form
1
Desmopressin-containing product in parenteral dose form
1
Efmoroctocog alfa-containing product in parenteral dose form
1
Eltrombopag-containing product in oral dose form
1
Emicizumab-containing product in parenteral dose form
1
Etamsylate-containing product in oral dose form
2
Gelatin-containing product in cutaneous dose form
1
Human fibrinogen-containing product in parenteral dose form
1
Moroctocog alfa-containing product in parenteral dose form
1
Octocog alfa-containing product in parenteral dose form
1
Oxidized cellulose-containing product in cutaneous dose form
1
Recombinant antihemophilic factor pegylated liposome-containing product in parenteral dose form
1
Recombinant coagulation factor IX-containing product in parenteral dose form
4
Romiplostim-containing product in parenteral dose form
1
Thrombin-containing product in cutaneous dose form
2
Tranexamic acid-containing product in oral dose form
2
Tranexamic acid-containing product in parenteral dose form
1
von Willebrand factor-containing product in parenteral dose form
2
